Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patients
Posted by
www.biotecnika.org
M P Gupta, general manager of Mahima Lifesciences, a Chandigarh-based
steroid API maker, said the company was expecting a jump in raw
material costs and possible supply disruption if demand goes up.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-drug-firms-cheer-dexamethasone-efficacy-on-severe-covid-19-patients/articleshow/76437755.cms
Subscribe to:
Post Comments (Atom)
Post a Comment